MAXINE MALEKMEHR: Open Payments
NPI 1871282152 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,047 in 49 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $473 · 2025 $1,047
Food & beverage: $1,047
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $387 |
| Collegium Pharmaceutical, Inc. | 13 | $155 |
| Saluda Medical Americas, Inc. | 3 | $85 |
| ABBVIE INC. | 4 | $70 |
| Globus Medical, Inc. | 3 | $60 |
| Averitas Pharma Inc. | 2 | $51 |
| Pacira Pharmaceuticals Incorporated | 1 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Valinor Pharma, LLC | 2 | $30 |
| Foundation Fusion Solutions, LLC | 1 | $26 |
Products named: WaveWriter Alpha Prime 16, Intracept, Belbuca, Evoke, QUTENZA, Exparel, UBRELVY, Senza.
Industry payments across CA — which companies pay providers there.
